AI assistant
Sending…
Applied Therapeutics, Inc. — Director's Dealing 2023
Sep 20, 2023
34263_dirs_2023-09-19_495fb4b1-4b82-4072-9b93-8df45a8be8af.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2023-09-15
Reporting Person: MARCUS JOEL S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-15 | Common Stock | M | 12375 | $1.05 | Acquired | 453414 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-09-15 | Employee Stock Option (Right to Buy) | $1.05 | M | 12375 | Disposed | 2032-06-02 | Common Stock (12375) | Direct |
Footnotes
F1: These options are fully vested.
More from Applied Therapeutics, Inc.
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 4
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
M&A Activity
2026
Feb 3
Regulatory Filings
2026
Feb 3
Director's Dealing
2026
Feb 3
Delisting Announcement
2026
Feb 3
Director's Dealing
2026
Feb 3